viewInnovaDerma PLC

InnovaDerma 'well-positioned' with a strong pipeline of new products and markets

InnovaDerma PLC's (LON:IDP) Joe Bayer and Kieran Callan talk Proactive London's Andrew Scott through their half year report as well as updating on new products and plans.

In its results statement covering the six months to the end of 2019, the developer of beauty, personal care and life science products said it had been a period of strong progress.

''The second half of the year is our big half as we go into season in the UK ... there's a lot of activity, we have a lot of product development coming out, we've got the relationships with Boots and Superdrug ... so we are expecting  a very strong second half''.

Quick facts: InnovaDerma PLC

Price: 59 GBX

Market: LSE
Market Cap: £8.55 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of InnovaDerma PLC named herein, including the promotion by the Company of InnovaDerma PLC in any Content on the Site, the Company receives from...


InnovaDerma reports strong cash and 'resilient performance' during pandemic

InnovaDerma PLC's (LON:IDP) chairman Joe Bayer and CEO Kieran Callan tell Proactive London's Andrew Scott the business has performed resiliently during the coronavirus pandemic lockdown but have been hit by rising advertising costs. Bayer says they now want to start swinging the earnings...

on 13/7/20

2 min read